Bioactivity | p38-α MAPK-IN-1 is an inhibitor of MAPK14 (p38-α), with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay[1]. | ||||||||||||
Target | IC50: 2300 nM (p38-α, in EFC assay), 5500 nM (p38-α, in HTRF assay) | ||||||||||||
Invitro | p38-α MAPK-IN-1 (Compound 12) is an inhibitor of MAPK14 (p38-α)>, with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay[1]. | ||||||||||||
Name | p38-α MAPK-IN-1 | ||||||||||||
CAS | 443913-15-3 | ||||||||||||
Formula | C27H35N5O3 | ||||||||||||
Molar Mass | 477.60 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Kluter S, et al. Displacement assay for the detection of stabilizers of inactive kinase conformations. J Med Chem. 2010 Jan 14;53(1):357-67. |